Pharmacological outlook of Lenacapavir: a novel first-in-class Long-Acting HIV-1 Capsid Inhibitor
2023 · Infezioni in Medicina · 14 citations
https://doi.org/10.53854/liim-3104-8
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
4
Papers
68
Citations
4
h-index
2
i10-index
Giovanni Di Perri is an academic researcher from Ospedale Amedeo di Savoia. The author has contributed to research in topics: HIV/AIDS drug development and treatment & Tuberculosis Research and Epidemiology & Pneumocystis jirovecii pneumonia detection and treatment. The author has an h-index of 4, co-authored 4 publications.
Click to start Chat